These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9860399)

  • 21. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
    Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
    Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
    Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipids and inflammation in active inflammatory bowel diseases.
    Romanato G; Scarpa M; Angriman I; Faggian D; Ruffolo C; Marin R; Zambon S; Basato S; Zanoni S; Filosa T; Pilon F; Manzato E
    Aliment Pharmacol Ther; 2009 Feb; 29(3):298-307. PubMed ID: 19035968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
    Federico A; Tuccillo C; Grossi E; Abbiati R; Garbagna N; Romano M; Tiso A; Blanco Cdel V; Loguercio C
    Eur Rev Med Pharmacol Sci; 2009; 13(4):285-93. PubMed ID: 19694343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression with TGFbeta1 in the patients with ulcerative colitis].
    Wang YF; Wei B; Ouyang Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha.
    Churchill L; Taishi P; Wang M; Brandt J; Cearley C; Rehman A; Krueger JM
    Brain Res; 2006 Nov; 1120(1):64-73. PubMed ID: 17022949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.
    Peterson CG; Sangfelt P; Wagner M; Hansson T; Lettesjö H; Carlson M
    Scand J Clin Lab Invest; 2007; 67(8):810-20. PubMed ID: 18034391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of OX40 in CD4+ T cells cytokines production in ulcerative colitis].
    Wang XD; Wu TY
    Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):15-8. PubMed ID: 18346319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis.
    Rachmilewitz D; Eliakim R; Ackerman Z; Karmeli F
    Am J Gastroenterol; 1998 Mar; 93(3):409-12. PubMed ID: 9517649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease.
    López-Hernández R; Valdés M; Campillo JA; Martínez-García P; Salama H; Bolarin JM; Martínez H; Moya-Quiles MR; Minguela A; Sánchez-Torres A; Botella C; Salgado G; Miras M; Carballo F; Muro M
    Int J Immunogenet; 2015 Feb; 42(1):38-45. PubMed ID: 25359546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity.
    Ufer M; Häsler R; Jacobs G; Haenisch S; Lächelt S; Faltraco F; Sina C; Rosenstiel P; Nikolaus S; Schreiber S; Cascorbi I
    Pharmacogenomics; 2009 Dec; 10(12):1941-53. PubMed ID: 19958093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigational cytokine-targeted therapies for ulcerative colitis.
    Monteleone G; Pallone F; Caprioli F
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1123-32. PubMed ID: 23802627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines and Behcet's disease.
    Zhou ZY; Chen SL; Shen N; Lu Y
    Autoimmun Rev; 2012 Aug; 11(10):699-704. PubMed ID: 22197901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
    Tang H; Xiang D; Wang F; Mao J; Tan X; Wang Y
    Mol Med Rep; 2017 Mar; 15(3):1117-1122. PubMed ID: 28138699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.